These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 7564425)
41. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911 [TBL] [Abstract][Full Text] [Related]
42. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
44. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer. Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135 [TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease. Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188 [TBL] [Abstract][Full Text] [Related]
46. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases]. Zhang GQ; Han F; Gao SL; A DL; Pang ZL Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944 [TBL] [Abstract][Full Text] [Related]
48. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer. Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636 [TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193 [TBL] [Abstract][Full Text] [Related]
50. Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer. Liu CY; Hung JJ; Wang BY; Hsu WH; Wu YC Eur Respir J; 2013 Mar; 41(3):649-55. PubMed ID: 22835612 [TBL] [Abstract][Full Text] [Related]
51. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079 [TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm. Hung JJ; Jeng WJ; Hsu WH; Lin SF; Hsieh CC; Huang BS; Huang MH; Liu JS; Chou TY; Wu YC Eur Respir J; 2010 Dec; 36(6):1355-61. PubMed ID: 20516056 [TBL] [Abstract][Full Text] [Related]
53. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Suzuki K; Nagai K; Yoshida J; Nishimura M; Takahashi K; Yokose T; Nishiwaki Y Cancer; 1999 Nov; 86(10):1976-84. PubMed ID: 10570421 [TBL] [Abstract][Full Text] [Related]
54. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
55. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650 [TBL] [Abstract][Full Text] [Related]
56. [Prognostic factors of operated non-small-cell bronchogenic cancer: critical analysis of T.N.M]. Riquet M; Manac'h D; Le Pimpec Barthes F; Souilamas R; Paris E; Dujon A; Debesse B Rev Pneumol Clin; 1996; 52(3):181-7. PubMed ID: 8763637 [TBL] [Abstract][Full Text] [Related]
57. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer. Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967 [TBL] [Abstract][Full Text] [Related]
58. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer. Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095 [TBL] [Abstract][Full Text] [Related]
59. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer]. Liu JW; Li J; Lin G; Shang XQ Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301 [TBL] [Abstract][Full Text] [Related]
60. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer]. Gao YS; Xing XZ; Shao K; Feng XL; He J Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]